EUVIMEDEUVIMED entdecken
Crossref

Neoadjuvant TP (Cisplatin-Docetaxel) for patients unfit to TPF (Cisplatin-Docetaxel-5FU) in locally advanced head and neck squamous cell cancer (LAHNSCC): an exploratory study on 14 patients

Jérôme Fayette, Emilie Lavergne, Antoine Ramade, Philippe Zrounba, Didier Girodet, Eve-Marie Neidhardt, Sylvie Chabaud, Julien Péron, Marc Poupart, Philippe Céruse

Otorhinolaryngology-Head and Neck Surgery · 2016

DOI: 10.15761/ohns.1000113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Otorhinolaryngology-Head and Neck Surgery, 2016. Verfasst von Jérôme Fayette und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Fayette, J., Lavergne, E., Ramade, A., Zrounba, P., Girodet, D., Neidhardt, E., Chabaud, S., Péron, J., Poupart, M., & Céruse, P. (2016). Neoadjuvant TP (Cisplatin-Docetaxel) for patients unfit to TPF (Cisplatin-Docetaxel-5FU) in locally advanced head and neck squamous cell cancer (LAHNSCC): an exploratory study on 14 patients. Otorhinolaryngology-Head and Neck Surgery. https://doi.org/10.15761/ohns.1000113

Vancouver

Fayette J, Lavergne E, Ramade A, Zrounba P, Girodet D, Neidhardt E, et al. Neoadjuvant TP (Cisplatin-Docetaxel) for patients unfit to TPF (Cisplatin-Docetaxel-5FU) in locally advanced head and neck squamous cell cancer (LAHNSCC): an exploratory study on 14 patients. Otorhinolaryngology-Head and Neck Surgery. 2016. doi:10.15761/ohns.1000113

BibTeX
@article{Fayette2016,
  author = {Fayette, Jérôme and Lavergne, Emilie and Ramade, Antoine and Zrounba, Philippe and Girodet, Didier and Neidhardt, Eve-Marie and Chabaud, Sylvie and Péron, Julien and Poupart, Marc and Céruse, Philippe},
  title = {Neoadjuvant TP (Cisplatin-Docetaxel) for patients unfit to TPF (Cisplatin-Docetaxel-5FU) in locally advanced head and neck squamous cell cancer (LAHNSCC): an exploratory study on 14 patients},
  journal = {Otorhinolaryngology-Head and Neck Surgery},
  year = {2016},
  doi = {10.15761/ohns.1000113}
}
Kostenlos starten →